Therapeutic Challenges Analysis (TCA) is a new breed of consulting firm dedicated to the integration of Market Access into all key strategic decisions along the pharmaceutical value chain. We believe that successful Market Access starts as early as the selection of diseases and indications for the allocation of Research resources, and is then driven more by the definition of Target Product Profiles and by the design of the Clinical Development program, than by the details of dossier writing or pricing. We consider payers as valued partners to the pharmaceutical industry who should be involved through the full development process. To our clients, we bring a unique understanding of payer’s belief systems and decision processes, along with privileged relationships with “real payers” nurtured through joint development of intellectual capital. Our small and senior TCA team has expertise in all key functions of the pharmaceutical industry (clinical development, business development, medical affairs, brand management, commercial), allowing to seamlessly integrate payer’s feedback and requirements into strategic decisions. We are not a pricing and reimbursement consulting firm. We are a Strategic Market Access consulting firm focusing on resolving Payer Value Uncertainty and on optimizing the value of development assets. • Visit http://www.therachallenges.com/offering.html to learn more